FDA Takes Shot Across the Bow with LDT Rulemaking
The FDA has issued proposed LDT rulemaking. Laboratories have an opportunity to make comments before it becomes official.
Read MorePosted by Chris Wolski | Oct 19, 2023 | Compliance |
The FDA has issued proposed LDT rulemaking. Laboratories have an opportunity to make comments before it becomes official.
Read MorePosted by Chris Wolski | Oct 10, 2023 | Flu & Respiratory Infections |
A parallel test developed by Karius aims to improve treatment for serious diseases by diagnosing infections more rapidly and effectively.
Read MorePosted by Chris Wolski | Sep 26, 2023 | Sepsis |
Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Gastrointestinal Infections |
Hospital-onset infections still occur—the most common caused by C. diff, the culprit in almost half a million infections yearly in the U.S.
Read MorePosted by Andy Lundin | Sep 15, 2023 | Company News |
New Day Diagnostics announced that the extraordinary general meeting of Epigenomics AG approved the acquisition agreement.
Read More